arrow
R

Rita Trozzi

department of women’s
H指数:8
被引数:321

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations

POLE突变晚期子宫内膜癌的临床和分子异质性:聚焦于侵袭性亚组和共突变

2026-04-290
OA
EC_italynch: mainstreaming genetic testing for lynch syndrome in patients with endometrial cancer.

EC_italynch: 在子宫内膜癌患者中推广林奇综合征的基因检测。

2026-02-170
PRE
Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers

破译上皮性卵巢癌的脑转移: 多模态分析和潜在的生物标志物

2026-01-190
OAAI
Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancer

根据分子靶点临床可操作性量表(ESCAT)评估的,无特定分子特征(NSMP)子宫内膜癌的基因可操作性

2025-09-030
OAAI
Improving Endometrial Cancer Assessment By Combining The New TechniqUe Of GENomic Profiling With Surgical Extra UterIne DisEase Assessment (EUGENIE). Second Interim Analysis After Two Years Of Enrolment

通过结合基因组图谱新技术与外科子宫外病变评估(EUGENIE),改进子宫内膜癌评估。两年入组后的第二次中期分析。

2025-02-010
PRE
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) At Interval Cytoreductive Surgery For Advanced Ovarian Cancer: Perioperative Outcomes Of Different Administration Tecniques

腹腔热灌注化疗(HIPEC)在间隔减灭术治疗晚期卵巢癌中的应用:不同给药技术的围手术期结果

2025-02-010
PRE
Outcomes Of Secondary Cytoreductive Surgery In Patients With Platinum-Sensitive Recurrent Ovarian Cancer Progressed After Prior Poly Adenosine Diphosphate-Ribose Polymerase Inhibitors (PARP-I) Maintenance: A Case-Control Study

铂敏感复发性卵巢癌患者经多聚腺苷二磷酸核糖聚合酶抑制剂(PARP-I)维持治疗后进展行二次细胞减灭术的结局:一项病例对照研究

2025-02-010
PRE
POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single-center cohort

子宫内膜癌中的POLE突变:来自大型前瞻性单中心队列的临床与基因组特征

CANCER
IF5.1
2025-01-250
OAAI
Reproductive, obstetrical and oncological outcomes of fertility-sparing treatment for cervical cancer according to the FIGO 2018 staging system: A systematic review

根据FIGO 2018分期系统,保留生育能力治疗宫颈癌的生殖,产科和肿瘤学结果: 系统评价

EJSO
IF2.9
2025-01-012
PRE
A monocentric analysis of ESCAT gene actionability detection in non-specific molecular profile (NSMP) early-stage endometrial cancer

非特异性分子表型(NSMP)早期子宫内膜癌中ESCAT基因可操作性的单中心分析

2024-09-010
PRE
Identification of a False-positive Multiplex Ligation- dependent Probe Amplification Result in BRCA1 Using a Copy Number Variation Algorithm Under Development for a Commercial Next-Generation Sequencing-based Homologous Recombination Deficiency Assay
2024-05-310
OAAI
ASO Visual Abstract: Expanding the Use of HIPEC in Ovarian Cancer at the Time of Interval Debulking Surgery to FIGO Stage IV After Six Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis of Perioperative and Oncologic Outcomes
2024-03-311
PRE
Mutational and gene expression profiles of the primary tumor and matched brain metastasis of epithelial ovarian cancer reveal differences in LAMC3 and MYC target genes
2024-03-220
PRE
Digital spatial transcriptomic reveals different epithelial and immune cells signatures across endometriosis-related diseases: From simple ovarian endometriosis to ovarian cancer
2024-03-220
PRE